Archives of Otol

Hosted by
American Head & Neck Society
July 21-25, 2012
Metro Toronto Convention Centre
Toronto, ON, Canada

Tips on Using this Site
Locate an abstract by entering any author's surname into the search box.

Broaden your search by typing only a few letters of a keyword; do not append the wildcard “*” to a search string.

Type too small? In most browsers, press Control “+” to enlarge type size. Reset by pressing Control “0”.

Results. To view an abstract, click on a title within results. Presenters’ names are underlined among the list of authors.

Presentation: P085
Topic: Larynx/Oral Cavity
Type: Poster
Date: Sunday - Tuesday, July 22 - 24, 2012
Session: Designated Poster viewing times
Authors: Ryuji Yasumatsu, MD, Torahiko Nakashima, MD, Shizuo Komune, MD
Institution(s): Department of Otolaryngology, Kyushu University, Japan

Primary tracheal tumors are rare consisting only two per cent of all respiratory tract tumors. Squamous cell carcinoma (SCC) is the most common pathology in smokers, and adenoid cystic carcinoma (ACC) is more prevalent among non-smokers. This study retrospectively evaluated treatments for patients with tracheal cancer.

Materials and Methods:
Five patients with tracheal cancer were treated between 2001 and 2011. There were 3 males and 2 females, ranging in age from 58 to 77 years. All patients had symptoms such as cough, breathlessness and hemoptysis. Histologically, 3 cases were SCC and 2 were ACC. Three patients with SCC were habitual smokers.

Chemo-radiotherapy was applied for 1 case, and surgical treatment for the other 4 cases. Two of 4 patients underwent manubrial resection and anterior mediastinal tracheostomy and one patient underwent pharyngolaryngectomy and free jejunal transfer. One patient was treated by laser resection with tracheostomy. One patients with a microscopic residual tumor required postoperative external radiotherapy. There were no postoperative complications such as mediastinal infection or anastomotic leakage etc.

Primary tracheal tumors tend to be diagnosed late on account of delayed specific symptoms such as hemoptysis, dyspnea, cough, hoarseness. When patients do not present blood in the sputum, the initial diagnosis is thought to be bronchial asthma in many cases and suffocation sometimes occurs before surgical treatment. Therefore, careful examination including bronchoscopic evaluation and the CT scan is recommended. The diagnosis and treatment strategy for this rare tumor will be discussed.


cyklokapron canada cyklokapron virkning

JAMA Network Logo
© 2022 American Medical Association. All Rights Reserved.      Conditions of Use       Privacy Policy     Toronto skyline by John Vetterli (cc-by-sa-2.0)